These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Antibody engineering and therapeutics conference. The annual meeting of the antibody society, Huntington Beach, CA, December 7-11, 2014. Larrick JW; Parren P; Huston JS; Plückthun A; Bradbury A; Tomlinson IM; Chester KA; Burton DR; Adams GP; Weiner LM; Scott JK; Alfenito MR; Veldman T; Reichert JM MAbs; 2014; 6(5):1115-23. PubMed ID: 25517297 [TBL] [Abstract][Full Text] [Related]
43. Enzyme Engineering XII. Conference proceedings. Deauville, France, September 19-24, 1993. Ann N Y Acad Sci; 1995 Mar; 750():1-506. PubMed ID: 7785835 [No Abstract] [Full Text] [Related]
44. Antibody Engineering & Therapeutics 2016: The Antibody Society's annual meeting, December 11-15, 2016, San Diego, CA. Larrick JW; Alfenito MR; Scott JK; Parren PW; Burton DR; Bradbury AR; Lemere CA; Messer A; Huston JS; Carter PJ; Veldman T; Chester KA; Schuurman J; Adams GP; Reichert JM MAbs; 2016; 8(8):1425-1434. PubMed ID: 27557809 [TBL] [Abstract][Full Text] [Related]
45. Intrabody construction and expression. II. A synthetic catalytic Fv fragment. Ohage EC; Wirtz P; Barnikow J; Steipe B J Mol Biol; 1999 Sep; 291(5):1129-34. PubMed ID: 10518948 [TBL] [Abstract][Full Text] [Related]
46. Phage display of a catalytic antibody to optimize affinity for transition-state analog binding. Baca M; Scanlan TS; Stephenson RC; Wells JA Proc Natl Acad Sci U S A; 1997 Sep; 94(19):10063-8. PubMed ID: 9294163 [TBL] [Abstract][Full Text] [Related]
47. Antibody-Mediated Catalysis in Infection and Immunity. Bowen A; Wear M; Casadevall A Infect Immun; 2017 Sep; 85(9):. PubMed ID: 28674034 [TBL] [Abstract][Full Text] [Related]
48. Antibody Engineering & Therapeutics, the annual meeting of The Antibody Society December 7-10, 2015, San Diego, CA, USA. Pauthner M; Yeung J; Ullman C; Bakker J; Wurch T; Reichert JM; Lund-Johansen F; Bradbury AR; Carter PJ; Melis JP MAbs; 2016; 8(3):617-52. PubMed ID: 26909869 [TBL] [Abstract][Full Text] [Related]
56. [Isolation and characteristics of catalytic antibodies to DNA in systemic lupus erythematosis]. Gololobov GV; Bogomolova AE; Iadav RP; Ermolaeva MV; Belostotskaia KM; Prokaeva TB; Shuster AM; Gabibov AG Biokhimiia; 1993 Feb; 58(2):313-8. PubMed ID: 8485221 [TBL] [Abstract][Full Text] [Related]
57. Computational enzyme design. Kiss G; Çelebi-Ölçüm N; Moretti R; Baker D; Houk KN Angew Chem Int Ed Engl; 2013 May; 52(22):5700-25. PubMed ID: 23526810 [TBL] [Abstract][Full Text] [Related]
58. Nature and nurture of catalytic antibodies. Paul S; Planque SA; Nishiyama Y; Hanson CV; Massey RJ Adv Exp Med Biol; 2012; 750():56-75. PubMed ID: 22903666 [TBL] [Abstract][Full Text] [Related]
59. Catalytic activity of certain antibodies as a potential tool for drug synthesis and for directed prodrug therapies. Wójcik T; Kieć-Kononowicz K Curr Med Chem; 2008; 15(16):1606-15. PubMed ID: 18673227 [TBL] [Abstract][Full Text] [Related]
60. Proceedings of the XIIth International Conference on Surface Forces. Zvenigorod, Russia, June 29-July 5, 2002. Dedicated to the centennial of the birth of Professor Boris Vladimirovich Derjaguin. Adv Colloid Interface Sci; 2003 Jul; 104():IX-XX, 1-331. PubMed ID: 12818507 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]